# A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Ascending Dose and Multiple Doses With Titration of TAK-935 in Healthy Japanese Participants

> **NCT04461483** · PHASE1 · COMPLETED · sponsor: **Takeda** · enrollment: 33 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** TAK-935
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04461483
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-13
- **Primary completion:** 2020-11-14
- **Final completion:** 2020-11-14
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2022-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04461483

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04461483, "A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Ascending Dose and Multiple Doses With Titration of TAK-935 in Healthy Japanese Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04461483. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*